Author

Florentine Marx

Innsbruck Medical UniversityORCID 0000-0002-8408-1842Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Alessandra RomanelliiD· 1 shared Anik GeschwindtiD· 1 shared Anna SeyboldiD· 1 shared Attila FarkasiD· 1 shared Cristina SchöpfiD· 1 shared Csaba PappiD· 1 shared Débora Cristina Coraça-HuberiD· 1 shared Gábor BendeiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Alessandra RomanelliORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyJournal of FungiPeer-reviewedDec 23, 2025

Amphibian-derived peptide analog TB_KKG6K: A powerful drug candidate against Candida albicans with anti-biofilm efficacy

Cristina Schöpf, Anik Geschwindt, Magdalena Knapp…·Florentine Marx

This study identifies TB_KKG6K, an amphibian-derived peptide, as a potent antifungal agent effective against Candida albicans planktonic cells and biofilms, with no adverse effects on standard antifungal drugs.

2 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky

MicrobiologyMicrobiology SpectrumPeer-reviewedNov 19, 2024

The Neosartorya (Aspergillus) fischeri antifungal protein NFAP2 has low potential to trigger resistance development in Candida albicans in vitro

Gábor Bende, Nóra Zsindely, Krisztián Laczi…·László Galgóczy

This study shows that C. albicans develops resistance to NFAP2 with fewer genetic changes and less phenotypic impact than to fluconazole, suggesting NFAP2 is a promising antifungal with low resistance potential.

6 citations

humanexperimental assay

𝕏 PostBluesky